Evidence map›Paper›PMID 42574290›Full record

ArticleMedical principles and practice : international journal of the Kuwait University, Health Science Centre2026

Correlations of Free Beta-Human Chorionic Gonadotropin/Pregnancy-Associated Plasma Protein A Ratio, Pregnancy Characteristics, and Placental Pathology in Fetal Growth Restriction.

István Dankó, András Tankó, Edit Kelemen, Béla Temesváry, Gábor Cserni

Abstract read
In one paragraph

Article in Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

István DankóDepartment of Obstetrics and Gynecology, Bács-Kiskun County Teaching Hospital, Kecskemét, Hungary, dr.danist@gmail.com.
András TankóDepartment of Obstetrics and Gynecology, Bács-Kiskun County Teaching Hospital, Kecskemét, Hungary.
Edit KelemenPerinatal Intensive Centre, Bács-Kiskun County Teaching Hospital, Kecskemét, Hungary.
Béla TemesváryDepartment of Obstetrics and Gynecology, Bács-Kiskun County Teaching Hospital, Kecskemét, Hungary.
Gábor CserniDepartment of Pathology, Bács-Kiskun County Teaching Hospital, Kecskemét, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

<p>Objective: We evaluated the clinicopathological correlations of maternal serum free beta-human chorionic gonadotropin (FBHCG)/pregnancy-associated plasma protein A (PAPP-A) multiple of the median ratio measured between 11 + 0 and 13 + 6 weeks of gestation, pregnancy characteristics, and placental histopathology in pregnancies affected by fetal growth restriction (FGR). SUBJECTS AND

methodsWe investigated 69 pregnancies complicated with FGR. Different indicators of FGR, placental villous capillarization, placental weight to birth weight ratio, and placental histopathological entities were correlated with FBHCG/PAPP-A ratio.

resultsComplication of FGR with preeclampsia (p < 0.001) and birth weight below the 2nd percentile (p < 0.001) were significantly more common when the FBHCG/PAPP-A ratio was higher. Placental weight to birth weight ratio was significantly lower (<1:8) in cases of higher FBHCG/PAPP-A ratio. Distal villous hypoplasia (DVH), avascular villi (AV), and chorangiosis were more prevalent in cases with a higher FBHCG/PAPP-A ratio; however, villous capillarization, onset of FGR, oligohydramnios, and preterm birth did not have an association with it.

conclusionIn FGR, a higher FBHCG/PAPP-A ratio could be an early indicator of placental villous underdevelopment, which is further supported by the fact that higher prevalence of DVH and AV was described in cases with a higher FBHCG/PAPP-A ratio. We conclude that this ratio could be an early marker of potential placental dysfunction (and consecutive FGR later in pregnancy), rendering it a helpful marker as early as the end of the first trimester for identifying pregnancies that warrant close monitoring throughout gestation.</p>.

Indexed as

Fetal growth restrictionHistopathologyPlacentaPreeclampsia

Identifiers

PMID42574290
PMCPMC13580647

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.